Language NL EN DE ES FR UK IT

Rebuild analysis

Kartel Analysis

Clean base for MEP, document and thematic network analysis. No hard political labels, but auditable evidence.

You are here

ONTWERPRESOLUTIE over de begrotingsmaatregelen die moeten worden genomen om de economische gevolgen op te vangen van de verspreiding van COVID-19 voor de overheidsfinanciën van de lidstaten

You are viewing a dossier. From here you can see which actors, signals and linked vote events are visible around this document.

Jump to

Dossier Actors Sources and context Supporting layers Linked vote events

Dossier

ONTWERPRESOLUTIE over de begrotingsmaatregelen die moeten worden genomen om de economische gevolgen op te vangen van de verspreiding van COVID-19 voor de overheidsfinanciën van de lidstaten

Ontwerpresolutie | 2020-04-07 | source: plenary_documents

Open bronpagina Leesbare metadata Wikipedia zoeken

Pfizer en covid

20Actors

1Signals

9EP term

Actors

André Rougé

Role: co-author

Method: name-normalized | confidence 0.7500

Annika Bruna

Role: co-author

Method: name-normalized | confidence 0.7500

Aurélia Beigneux

Role: co-author

Method: name-normalized | confidence 0.7500

Catherine Griset

Role: co-author

Method: name-normalized | confidence 0.7500

France Jamet

Role: co-author

Method: name-normalized | confidence 0.7500

Gilbert Collard

Role: co-author

Method: name-normalized | confidence 0.7500

Gilles Lebreton

Role: co-author

Method: name-normalized | confidence 0.7500

Hélène Laporte

Role: co-author

Method: name-normalized | confidence 0.7500

Hervé Juvin

Role: co-author

Method: name-normalized | confidence 0.7500

Jean-François Jalkh

Role: co-author

Method: name-normalized | confidence 0.7500

Jean-Lin Lacapelle

Role: co-author

Method: name-normalized | confidence 0.7500

Jean-Paul Garraud

Role: co-author

Method: name-normalized | confidence 0.7500

Jérôme Rivière

Role: co-author

Method: name-normalized | confidence 0.7500

Jordan Bardella

Role: co-author

Method: name-normalized | confidence 0.7500

Julie Lechanteux

Role: co-author

Method: name-normalized | confidence 0.7500

Mathilde Androuët

Role: co-author

Method: name-normalized | confidence 0.7500

Maxette Pirbakas

Role: co-author

Method: name-normalized | confidence 0.7500

Nicolas Bay

Role: co-author

Method: name-normalized | confidence 0.7500

Thierry Mariani

Role: co-author

Method: name-normalized | confidence 0.7500

Virginie Joron

Role: co-author

Method: name-normalized | confidence 0.7500

Sources and context Source text and aggregated content + Provenance and audit

Source text and aggregated content

ONTWERPRESOLUTIE over de begrotingsmaatregelen die moeten worden genomen om de economische gevolgen op te vangen van de verspreiding van COVID-19 voor de overheidsfinanciën van de lidstaten

Provenance and audit

This block makes visible which source layer and datapoints the current view is based on.

Source layer plenary_documents

Canonical identifier B-9-2020-0140

Official source URL https://data.europarl.europa.eu/eli/dl/doc/B-9-2020-0140

Title and language layer Only Dutch title available

EP term 9

News context around this event

Use these links to quickly search reputable news sources around the event date using the title and keywords.

Search period: 2020-04-07

Keywords: ONTWERPRESOLUTIE over de begrotingsmaatregelen die moeten worden genomen om de economische gevolgen op te vangen van de…

Reuters Financial Times Politico Europe The Guardian NRC de Volkskrant Google News

Supporting layers Signals

Signals

topic-match / pfizer-covid

Value: 0.8000

ONTWERPRESOLUTIE over de begrotingsmaatregelen die moeten worden genomen om de economische gevolgen op te vangen van de verspreiding van COVID-19 voor de overheidsfinanciën van de lidstaten Jean-Lin LACAPELLE; Jean-Paul GARRAUD; Julie LECHA

Linked vote events Votes and seat distribution

Linked vote events

No official vote items linked to this dossier yet.

Next logical step

Use these routes to continue your research from this page.

Continue to topics Continue to evidence board Back to dashboard